http://rdf.ncbi.nlm.nih.gov/pubchem/patent/FR-2412550-A1

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_bdf849c32d7e0f41780c1a6b776dc1e3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07D498-08
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07D498-08
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-395
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-04
filingDate 1978-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationDate 1979-07-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber FR-2412550-A1
titleOfInvention 3-CARBOXYRIFAMYCINS S AND SV DERIVATIVES, PROCESS FOR THEIR PREPARATION, AND THEIR APPLICATION AS MEDICINAL PRODUCTS
abstract THESE DERIVATIVES ARE REPRESENTED BY THE TWO FOLLOWING FORMULAS. THEY ARE PREPARED BY OXIDATION OF CYANHYDRIN FROM 3-FORMYLRIFAMYCIN S TO 3- (CYANOCARBONYL) -RIFAMYCINS, CONDENSATION WITH A COMPOUND OF FORMULA HR (ALCOHOL, AMINE OR HYDRAZINE SUBSTITUTE) AND, OPTIONALLY ENDBOXYIN-3-CARBONYF-REDUCTION OF DAMS-3-FORMYLRIFAMYCIN THE CORRESPONDING FORMESV. AS AN ALTERNATIVE, 3- (CYANOCARBONYL) -RIFAMYCINS MAY BE CONVERTED TO THE V FORM BEFORE CONDENSATION WITH THE H-R COMPOUND. THESE DERIVATIVES MAY BE USED FOR THERAPEUTIC PURPOSES AND THEY CAN BE ADMINISTERED AS SUCH OR IN THE FORM OF SALTS, FOR THE TOPICAL OR GENERAL TREATMENT OF INFECTIOUS DISEASES SUCH AS PNEUMONIA, ABCES, FURUNCULOSIS, CYSTITIS, CHOLECYSTITIS, ETC. (CF DRAWING IN BOPI) RCN, OR (R ALIPHATIC GROUP CONTAINING 1-4C AND WHICH CAN PRESENT SUBSTITUTES CHOSEN FROM AMONG OH,
priorityDate 1977-12-20-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/DE-2728869-A1
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559527
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6438444
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID426107657
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID702
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID9321
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419538410

Total number of triples: 20.